PolyPeptide Group AG (PPGN) — Cash Flow Reinvestment Rate
PolyPeptide Group AG (PPGN) has a Cash Flow Reinvestment Rate of 0.98x as of June 2025, reinvesting CHF48.68 Million (capex CHF48.68 Million ) from operating cash flow of CHF49.66 Million. Explore PPGN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PolyPeptide Group AG Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for PolyPeptide Group AG across 7 annual periods. Also explore balance sheet size of PolyPeptide Group AG for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for PolyPeptide Group AG (2018–2024)
Year-by-year capital reinvestment analysis for PolyPeptide Group AG. For live market cap and broader valuation context, see market cap of PolyPeptide Group AG.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.99x | CHF177.99 Million | CHF89.40 Million | CHF86.97 Million | ▼ -37.5% |
| 2023 | 3.19x | CHF116.25 Million | CHF36.48 Million | CHF56.73 Million | ▼ -88.9% |
| 2022 | 28.79x | CHF157.20 Million | CHF5.46 Million | CHF78.76 Million | ▲ +1939.4% |
| 2021 | 1.41x | CHF80.97 Million | CHF57.35 Million | CHF77.71 Million | ▲ +70.9% |
| 2020 | 0.83x | CHF40.88 Million | CHF49.48 Million | CHF40.62 Million | ▲ +102.3% |
| 2019 | 0.41x | CHF22.70 Million | CHF55.60 Million | CHF19.70 Million | ▼ -49.6% |
| 2018 | 0.81x | CHF18.59 Million | CHF22.94 Million | CHF18.30 Million | — |